PLRX

Pliant Therapeutics, Inc.

12.37 USD
+0.01 (+0.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pliant Therapeutics, Inc. stock is up 14.96% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 July’s closed higher than June.

About Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins.